The Global Health Supply Chain Program – Procurement and Supply Management (GHSC-PSM) project (alternately referred to herein as “Chemonics” or “GHSC-PSM” or “Buyer”) is an official project of the United States Agency for International Development (USAID) implemented by Chemonics International and its consortium members. The purpose of GHSC-PSM is to ensure uninterrupted supplies of health commodities in support of USG-funded public health initiatives around the world. The project provides direct procurement and supply chain management support to the President’s Emergency Plan for AIDS Relief (PEPFAR), the President’s Malaria Initiative (PMI), and Population and Reproductive Health (PRH). GHSC-PSM supports health programs through the supply of a wide range of health commodities, including contraceptives and condoms, essential drugs; and select commodities for HIV/AIDS, malaria, maternal and child health, and infectious diseases.
As part of project activities, the GHSC-PSM Project requires the provision of the injectable hormonal contraceptives, Medroxyprogesterone Acetate, Depot 150 mg/mL, in 1mL vial (DMPA IM) and Depot (SC) Medroxyprogesterone Acetate 104 mg/0.65 mL, Pre-Filled Uniject Device, Auto-Disable (AD)/Single use Syringe and 5L Safety Box for USAID programs globally. Chemonics intends to enter into an indefinite delivery, indefinite quantity subcontract(s) with one or more Offeror(s).
Questions or requests regarding the technical or administrative requirements of the RFQ shall be submitted in writing to the following email addresses no later than July 5, 2019: email@example.com, firstname.lastname@example.org, and email@example.com. Once questions are received, GHSC-PSM will endeavor to respond by July 12, 2019. Submission of questions must be done in writing, via email to the above-mentioned parties. Where applicable, GHSC-PSM may combine and anonymize questions from multiple offerors and publish responses for all offerors. Phone calls will not be accepted. Only the written answers issued by GHSC-PSM will be considered official and carry weight in the RFQ process and subsequent evaluation. Any verbal information received from employees of the project, Chemonics International, Inc. or any other entity should not be considered as an official response to any questions regarding to this RFQ.
Please note that this RFQ will remain open for up to one (1) year with intermediary deadlines for submission. Suppliers currently eligible should submit offers by July 31, 2019 for review and evaluation. Awards will be made on the basis of an initial evaluation. Additional submissions will be accepted and reviewed upon receipt on a schedule to be determined and published.
- RFQ: GHSC-PSM-TO3-2019-INJ-IDIQ
- Annex 1: General Terms and Conditions
- Annex 2: Required Certifications
- Annex 3: Offer Cover Letter
- Annex 4: Product Specifications and Technical Requirements
- Annex 5: Price Quotation Form
- Annex 6: Registration Template
- Annex 7: Packaging Specifications
- Supplement 1: Finished Pharmaceutical Product Questionnaire (Abbreviated)
- Supplement 2: Finished Pharmaceutical Product Questionnaire
- Supplement 3: Instructions for Creating a GHSC-QA Technical Questionnaire Submission
- Supplement 4: Medical Device Product Questionnaire